Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Pharma Mar (PHMMF) had Cash Flow from Investing Activities of $-17.59M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$283.12M |
|
$62.08M |
|
$112.21M |
|
$395.33M |
|
$99.65M |
|
$42.65M |
|
$66.91M |
|
$166.56M |
|
$228.78M |
|
$227.50M |
|
$228.78M |
|
-- |
|
| Cash Flow Statement Financials | |
$3.25M |
|
|
Cash Flow from Investing Activities |
$-17.59M |
$-30.49M |
|
$71.79M |
|
$24.51M |
|
$-47.28M |
|
$0.19M |
|
$-15.83M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|